Randomized trial to assess the potential role of ascorbic acid and statin for post-contrast acute kidney injury prevention.

Abdelwahab HashemMahmoud LaymonMostafa ElgamalMohammed HegazyA M ElmeniarHuda RefaieYasser Osman

Published in: International urology and nephrology (2023)

Statin and ascorbic acid did not statistically improve neither serum creatinine nor eGFR values in patient underwent CECT. However, it can decrease the incidence of the clinically insignificant PC-AKI.

Keyphrases

acute kidney injury
cardiac surgery
cardiovascular disease
coronary artery disease
small cell lung cancer
epidermal growth factor receptor
low density lipoprotein
magnetic resonance
case report
tyrosine kinase
risk factors
uric acid
type diabetes
metabolic syndrome
contrast enhanced